Chlamydiae psittaci Vaccines

Creative Biolabs is a forward-looking research institute as well as a leading custom service provider in the field of vaccine development. Equipped with a team of professional scientists, we are capable of providing our clients with a variety of customized services in vaccine development for Chlamydiae psittaci vaccines. We guarantee the finest results for our customers all over the world.

Chlamydiae psittaci, a member of the Chlamydiae family, is the leading cause of enzootic abortion and fetal death in mammals, such as goats, sheep, as well as cattle. It is an intracellular bacterium and usually spreads through the feral birds and domesticated poultry with high mortality and morbidity. Chlamydiae psittaci infections have commonest initial symptoms which are similar to a ‘flu-like’ illness: headache, chills, fever, joint pains, and non-productive cough. However, it may show different symptoms over a period of time, for instance, an endemic avian in birds and respiratory psittacosis in human. More than 1 million infections can be found in many countries around the world. Chlamydiae psittaci vaccine is regarded as the best way to preventing Chlamydiae psittaci infection, and the data suggest that it is highly safe and efficient in clinic.

Fig.1 The Bacteria from Chlamydiae Family.

The Live Chlamydiae psittaci Vaccines

Chlamydiae psittaci is a lethal bacterium which is transmitted by birds and poultry. It can infect the hunter by the respiratory route and mostly presents as atypical pneumonia. Recent studies show that Chlamydiae psittaci has been reported in America, Canada, Australia, and several European areas. There is increasing concern on risk of Chlamydiae psittaci and on the development of Chlamydiae psittaci vaccines. The live Chlamydiae psittaci vaccines are available worldwide and have been proved to be safe in clinic. The live vaccines are derived from multiple Chlamydiae psittaci strains in different animals and cell cultures. With the advantage of genetically stable, highly immunogenic, it has played an important role in national immunization in many countries.

The DNA Chlamydiae psittaci Vaccines

Recent studies show that several DNA C. psittaci vaccines have been developed based on the major outer membrane protein (MOMP), a major protective antigen of Chlamydiae psittaci. The plasmid DNA expressing MOMP could provide a controllable protection against C. psittaci infection. Meanwhile, the efficacy of this DNA vaccine has been proven in mice models.

Our Services for Chlamydiae psittaci Vaccines

Our Chlamydiae psittaci vaccines platform, including in-depth discovery chemistry and biology, aims to offer streamlined development services from vaccine target identification to safety and toxicity studies. We have integrated high-quality viral services which are based in America and span the entire development chain from discovery to commercialization. Our laboratory services have many advanced chemical and biological technologies to support customer’s needs in the fast-growing vaccines development.

• One-stop vaccine manufacturing service
• Multiple and well-established vaccine development assay
• Efficient and cost-effective process

Creative Biolabs is pleased to share our cutting-edge technology and extensive expertise in the field of vaccine development. We can offer high-quality customized services by adjusting protocols to meet even the most specific requirements. If you are interested in our services, please contact us for more details.

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.